| Tag | Content |
|---|
EnhancerAtlas ID | HS111-03810 |
Organism | Homo sapiens |
Tissue/cell | KB |
Coordinate | chr4:74961720-74962750 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| STAT1 | MA0137.3 | chr4:74962033-74962044 | TTTCTAGGAAA | + | 6.14 | | Stat4 | MA0518.1 | chr4:74962033-74962047 | TTTCTAGGAAAGGG | + | 6.81 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_34944 | chr4:74962172-74967220 | HeLa | | SE_35924 | chr4:74962642-74966314 | HMEC |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH04I074092 | chr4 | 74958301 | 74962726 |
|
Enhancer Sequence | TTTATGGTTC TGTTATGACA CAAACTACTT GAGTTTTGAA AAACAAAATA TTTTAGCCAC 60
CATTTTATTG ACAGCTTCAT TAAATTGTCA ACAATTATAT GAAAAATTAT TTAGCAAAAG 120
CAAACAAATG CGATCCCTTG TTAAGATAAC TACAAGAATT TAATTTTTTT TAAATGAAAA 180
CAAGTTTATT AAGAAAGTAA AGCAATAAAG AGTGGCTATT CCATAGGCAA AGCAGCAGCC 240
TGAGCTGCTG GTTGGCCATT TTTATGGTTA TTTCTTGATT ATATGCTAAA CAAGGGGTGG 300
ACTATTCATG AGTTTTCTAG GAAAGGGGTG GGCAATTTCC TAGAACTGAG GGTTCCTCTC 360
TTTTTTAGAC CATACAGGGT AACTTCCTGA TGTTGCCATG ACACTTGTAA ACTGTCATGG 420
GGCTGGTAAG AGTGTCTTTT AGCATGCTAA TATATTATAA TTAGTGTATA ATGACGAGTG 480
AGAACGACAG AGGTCACTCT CGTCTCCATC TTGGCTTTGG TGGGTTTTAG CTGGCTTCTT 540
TACTGTAACC TGTTTTATCA GCAAGGTCTT TATGACCTGT ATCTTGTGCC AATCTCCTAT 600
CTCATCCTGT GACTTCGAAT GCCTAACCTA CTGGGAATGC AGCCCAGCCC AGTAAACCTC 660
AGCCCCATTT TGCCTAGCCC CTATTCAAGA TGGAGTTGCT CTGGTTAAAA CGTCTCTGCC 720
ATATTTCCCC CCTCCATATT TTTAAGGAGG TAAATTTGAG TAGCAAGGTA GTAAGGAACT 780
TCTTGTAAAA ATGGCAATAT GTATCAGTGA TTCTCCCATC AGGGGCAAGA CCATAGTTTG 840
GTAAGGCACA TTCTTTACTA GGTGAGAGCC AAGGGGAGTG ACAGCAATCA CCACATGAAA 900
TTAGGCATAA TTCATAGTTT ATCTGTATAG CAGATTGAAA ACCCAGAAAA AAATTGAGAA 960
ATAAATATTG ATGTAAATCA TCAGATTTTT CAGCAAATAT AGTCCTTGTT TCCCCCAAAA 1020
TAAAACAAAC 1030
|
